文献速递眼底病与葡萄膜炎

全身指标对初治糖尿病视网膜病变眼脉络膜厚度的影响

Effects of Systemic Profiles on Choroidal Thickness in Treatment-Naïve Eyes With Diabetic Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

本研究纳入136例初治糖尿病视网膜病变(DR)患者的136只眼及30名年龄匹配健康对照的30只眼,分析全身与眼部因素对黄斑中心凹下脉络膜厚度(SFChT)的影响。广义线性模型显示SFChT与DR分级及估算肾小球滤过率(eGFR)正相关,与年龄及血清磷水平负相关。调整年龄、eGFR和磷水平后,增殖期DR或重度非增殖期DR眼脉络膜厚于轻中度非增殖期DR或无DR眼。

要点

  • 初治DR眼SFChT与DR分级、eGFR正相关,与年龄、血清磷负相关。
  • 调整混杂后PDR与重度NPDR眼脉络膜较轻中度NPDR及无DR眼更厚。
  • 合并肾病严重程度与脉络膜变薄相关,提示全身状态影响脉络膜。

核心结论

  • 在糖尿病患者中,脉络膜受肾功能和DR分级影响,晚期视网膜病变与脉络膜增厚相关,合并肾病严重程度与脉络膜变薄相关。

研究设计与样本

  • 研究纳入初治DR患者,进行包括全血细胞计数、肝功能、肾功能及尿微量白蛋白尿检测在内的常规实验室评估。
  • 共纳入136例糖尿病患者的136只眼和30名年龄匹配健康对照的30只眼。
  • 分析DR中与SFChT变化相关的全身和眼部因素。

主要发现

  • 广义线性模型分析显示,初治DR眼SFChT与DR分级和eGFR正相关(P = 0.001)。
  • SFChT与年龄(P < 0.001)和血清磷水平(P = 0.001)负相关。
  • 调整年龄、eGFR和磷水平后,PDR眼(313.4 ± 9.0 µm)和重度NPDR眼(299.7 ± 9.7 µm)脉络膜厚于轻中度NPDR眼(251.7 ± 11.1 µm)和无DR眼(231.2 ± 14.5 µm)。

关键数值与推荐

  • PDR眼SFChT为313.4 ± 9.0 µm,重度NPDR眼为299.7 ± 9.7 µm。
  • 轻中度NPDR眼SFChT为251.7 ± 11.1 µm,无DR眼为231.2 ± 14.5 µm。
  • 上述厚度比较在调整年龄、eGFR和磷水平后进行。

临床怎么用

  • 评估初治DR患者脉络膜厚度时需同时考虑DR分级、年龄、eGFR和血清磷水平。
  • 合并肾功能损害较重的DR患者可能表现为脉络膜变薄,应结合全身指标解读OCT脉络膜厚度。

局限性

  • 原文未报告研究设计类型、纳入排除标准细节及随访情况。
  • 原文未报告糖尿病病程、血糖控制指标等全身因素的完整校正结果。
  • 原文未报告横断面设计能否推断因果关系的说明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to analyze the effects of systemic and ocular profiles on subfoveal choroidal thickness (SFChT) in treatment-naïve eyes with diabetic retinopathy (DR). METHODS: This study included patients with treatment-naïve DR. They underwent routine laboratory evaluations, including complete blood cell count, liver function tests, kidney function tests, and urinalysis for macroalbuminuria. The systemic and ocular factors associated with the change in SFChT in DR were analyzed. RESULTS: A total of 136 eyes from 136 patients with diabetes and 30 eyes from 30 age-matched healthy controls were recruited. Generalized linear model analyses showed that the SFChT in treatment-naïve eyes with DR was positively associated with the DR grade and estimated glomerular filtration rate (eGFR; P = 0.001) and negatively associated with age (P < 0.001) and serum phosphorus levels (P = 0.001). Treatment-naïve eyes with proliferative DR (PDR; 313.4 ± 9.0 µm) or severe nonproliferative DR (NPDR; 299.7 ± 9.7 µm) had thicker choroid than eyes with mild to moderate NPDR (251.7 ± 11.1 µm) or no DR (231.2 ± 14.5 µm) after adjusting for age, eGFR, and phosphorus levels. CONCLUSIONS: Choroid is affected by renal function and the grade of DR in patients with diabetes. Advanced retinopathy is associated with choroidal thickening, and the severity of concomitant renal disease is associated with choroidal thinning.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Choi MG, Chung H, Yoon YH, et al. Effects of Systemic Profiles on Choroidal Thickness in Treatment-Naïve Eyes With Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2020. PMID: 32902577. doi:10.1167/iovs.61.11.12

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。